Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 112 results for "biocon"

Biocon to consider recommendation of final dividend

We wish to inform you that, consideration and recommendation of final dividend, if any, for the financial year 2016-17 forms part of the agenda of the meeting of Board of Directors of the company, scheduled on Thursday, April 27, 2017. Money Control, 4 days ago

113 images for biocon

Money Control, 3 weeks ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Business Standard, 2 months ago
Money Control, 2 months ago
Livemint.com, 2 months ago
India Infoline

Top buzzing midcap stocks to trade on April 12

Here are a few top buzzing midcap stocks picked by CNBC-TV18#39;s analysts in trade today -- Biocon, Shilpa Medicare, Cairn, Vedanta, Karnataka Bank, Reliance Defence, Goa Carbon, Adani Power, Tata Power and Eicher Motors.
 Money Control1 week ago Top 14 stocks in focus today: Bharti Airtel, Biocon, Wockhardt  India Infoline2 months ago
Money Control

Biocon to sell Parit in India after Eisai ends 12-year partnership with GSK

Biocon’s push in a crowded segment is viewed as interesting considering that in the last two years, the company has consciously moved out of products that have seen fierce competition.
 Money Control3 weeks ago Biocon partners with Eisai to markets its anti-ulcer drug in India  Money Control3 weeks ago Biocon rises on strong results, new contract; looks headed for further upmove  Sify2 months ago Biocon bags Rs 460 crore contract for insulin in Malaysia  Business Standard2 months ago
[x]  
Business Standard

Mylan inks settlement pact with Genentech & Roche on cancer drug Herceptin

Trastuzumab (Herceptin) is one of the 6 biologic products co-developed by Mylan & Biocon BS B2B Bureau | Pittsburgh, USA March 14, 2017 Last Updated at 16:28 IST Mylan NV has agreed to the terms of a global settlement with Genentech Inc and F. Hoffmann-La ...
 Business Standard1 month ago Biocon and Mylan get USFDA approval to jointly develop biologic product  First Post.com2 months ago Biocon at new high; FDA accepts BLA for biosimilar Pegfilgrastim  Money Control2 months ago US FDA accepts application of Mylan & Biocon for biosimilar pegfilgrastim  Business Standard2 months ago
[x]  

HC allows Biocon, Mylan to sell their drug for three cancers

The Delhi High Court today allowed drug companies Biocon and Mylan to sell their version of Trastuzumab for two kinds of breast cancer and metastatic gastric cancer in view of the approval granted to it by the Drugs Controller General of India (DCGI).
 DNA1 month ago Setback for Roche: Mylan, Biocon can now sell generics of its cancer drug  Business Standard1 month ago Biocon jumps 5% on HC nod to make sell cancer drug  Money Control1 month ago
Money Control

Biocon, Alkem Labs surge on US FDA nods to products

Biocon surged after Mylan got a nod for breast cancer tablets, while Alkem Labs rose due to a nod for an ointment to treat ventricular tachycardia.
 Money Control1 month ago According to Biocon and Mylan, their respective breast  DNA2 months ago Can Biocon, Mylan drugs be used for early breast cancer: HC  DNA2 months ago

Shaw says 26-week maternity leave may not be sustainable for cos

The passage of the #39;Maternity Bill#39; has given the Indian women a reason to cheer. However, Biocon Chief Kiran Mazumdar Shaw is of the opinion that the 26-week leave will not be sustainable for companies. She said that there is a need to re-look into the ...
 Money Control1 month ago To cut healthcare costs, US must partner India: Biocon's Shaw  Money Control1 month ago Ban open burning of all wastes, says Biocon's Kiran Mazumdar-Shaw  Business Standard2 months ago Biocon well-poised to be a frontrunner in biosimilars: MD  Money Control2 months ago

Syngene to develop nutrition products for Herbalife

Syngene, the contract research and manufacturing unit of Biocon is looking to expand its business to work on products for customers that target Indian consumers. It has signed up HerbalLife Nutrition, a nutrition company to develop nutrition based products ...
 Business Standard1 month ago Herbalife, Syngene launch Nutrition R&D lab in India  DNA1 month ago
Money Control

Support for Nifty at 9080-9050; buy Biocon, Dish TV: Prakash Gaba

According to Prakash Gaba of prakashgaba.com, Nifty has support at 9080-9050 and resistance at 9150 while Bank Nifty has support at 20800 and resistance at 21200.
 Money Control1 month ago
Money Control

National Health Policy: Hospitals can become huge job creators, says Biocon Chief

NULL
 Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less